We are live on ! Find out more
ZYME icon

Zymeworks

115 hedge funds and large institutions have $512M invested in Zymeworks in 2023 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 36 increasing their positions, 27 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 20

72% more call options, than puts

Call options by funds: $2.46M | Put options by funds: $1.43M

33% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 27

20% more funds holding

Funds holding: 96115 (+19)

14% more capital invested

Capital invested by funds: $450M → $512M (+$62.5M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

2.31% less ownership

Funds ownership: 90.84%88.53% (-2.3%)

Holders
115
Holders Change
+19
Holders Change %
+19.79%
% of All Funds
1.83%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
40
Increased
36
Reduced
27
Closed
20
Calls
$2.46M
Puts
$1.43M
Net Calls
+$1.02M
Net Calls Change
+$998K
Name Holding Trade Value Shares
Change
Change in
Stake
AA
126
AlphaCentric Advisors
Puerto Rico
-$413K -52,500 Closed
Invesco
127
Invesco
Georgia
-$402K -51,180 Closed
Parallax Volatility Advisers
128
Parallax Volatility Advisers
California
-$236K -30,000 Closed
Group One Trading
129
Group One Trading
Illinois
-$244K -27,939 Closed
Walleye Trading
130
Walleye Trading
New York
-$192K -24,378 Closed
FWM
131
Forefront Wealth Management
Pennsylvania
-$128K -13,400 Closed
AGM
132
Alpine Global Management
New York
-$103K -13,046 Closed
Rockefeller Capital Management
133
Rockefeller Capital Management
New York
-$11K -1,500 Closed
NA
134
NewEdge Advisors
Louisiana
-$786 -100 Closed

ZYME Hedge Fund Activity: Q1 2023 in Review

115 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q1 2023, worth a combined $512M — up 14% from $450M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new ZYME positions and 20 closed out — a net gain of 20 holders — while 36 added to existing stakes and 27 trimmed.

The largest buyer was EcoR1 Capital, adding an estimated $22M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $13.4M sold.

  • 115 institutional investors held Zymeworks (ZYME) as of Q1 2023, up from 96 in Q4 2022.
  • Funds reported $512M of Zymeworks stock for Q1 2023, up 14% quarter-over-quarter.
  • 40 funds opened new Zymeworks positions in Q1 2023 and 20 closed out, a net change of +20 holders.
  • The largest Zymeworks buyer in Q1 2023 was EcoR1 Capital, an estimated $22M added.
  • The largest Zymeworks seller in Q1 2023 was Baker Bros. Advisors, an estimated $13.4M sold.

Based on aggregated 13F filings for Q1 2023.